Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
204.53
+5.17 (2.59%)
At close: May 13, 2026, 4:00 PM EDT
204.53
0.00 (0.00%)
After-hours: May 13, 2026, 7:12 PM EDT

Biogen Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
30,19625,81822,29637,49639,90435,268
Market Cap Growth
71.67%15.80%-40.54%-6.04%13.15%-5.49%
Enterprise Value
32,01028,57924,80243,63441,61638,134
Last Close Price
204.53175.99152.92258.77276.92239.92
PE Ratio
22.0020.0213.6832.4713.2723.07
Forward PE
15.2113.669.7117.5417.7013.94
PEG Ratio
6.854.751.904.3817.6839.30
PS Ratio
3.042.612.303.813.923.21
PB Ratio
1.621.411.332.532.983.24
P/TBV Ratio
1.611.421.342.553.023.29
P/FCF Ratio
12.4612.598.1929.5234.8810.43
P/OCF Ratio
11.6611.717.7524.2328.839.69
EV/Sales Ratio
3.222.892.564.444.093.47
EV/EBITDA Ratio
9.1010.828.4920.7110.4011.46
EV/EBIT Ratio
11.7915.3511.0327.0611.9513.42
EV/FCF Ratio
13.2113.949.1134.3536.3811.28
Debt / Equity Ratio
0.350.360.290.490.490.60
Debt / EBITDA Ratio
2.402.492.273.481.652.28
Debt / FCF Ratio
2.713.212.445.785.782.25
Net Debt / Equity Ratio
0.100.150.260.430.130.35
Net Debt / EBITDA Ratio
0.661.051.462.980.431.14
Net Debt / FCF Ratio
0.751.351.564.951.511.12
Asset Turnover
0.340.340.350.380.420.45
Inventory Turnover
1.181.040.931.311.691.74
Quick Ratio
2.181.700.770.922.151.34
Current Ratio
3.062.681.352.002.991.83
Return on Equity (ROE)
7.43%7.39%10.36%8.24%24.33%15.96%
Return on Assets (ROA)
5.55%5.38%7.02%5.62%11.85%11.36%
Return on Invested Capital (ROIC)
7.39%6.90%8.52%7.33%17.08%15.58%
Return on Capital Employed (ROCE)
7.35%7.66%9.80%7.22%17.05%14.04%
Earnings Yield
4.54%4.99%7.31%3.08%7.54%4.33%
FCF Yield
8.02%7.94%12.21%3.39%2.87%9.59%
Buyback Yield / Dilution
-1.01%-0.82%-0.21%0.27%2.41%7.25%
Total Shareholder Return
-1.01%-0.82%-0.21%0.27%2.41%7.25%
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q